Page last updated: 2024-10-24

regulation of transmission of nerve impulse

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. [GOC:ai]

The transmission of nerve impulses, also known as action potentials, is a complex process that relies on the coordinated action of several key components. Here's a detailed breakdown:

**1. Resting Membrane Potential:**
* The neuron is at rest, with a negative charge inside the cell compared to the outside. This difference in charge, called the resting membrane potential, is maintained by the sodium-potassium pump, which actively pumps three sodium ions out of the cell for every two potassium ions pumped in.
* The cell membrane is selectively permeable, meaning it allows some ions to pass through more easily than others. At rest, the membrane is more permeable to potassium ions, allowing them to leak out, contributing to the negative charge inside the cell.

**2. Depolarization:**
* When a stimulus, like a neurotransmitter or a change in the environment, excites the neuron, it triggers the opening of sodium channels in the cell membrane.
* Sodium ions, which are positively charged, rush into the cell, causing the membrane potential to become less negative (i.e., it depolarizes).

**3. Threshold Potential:**
* If the depolarization reaches a critical threshold, an action potential is triggered. This threshold is the point at which the neuron "fires."

**4. Action Potential:**
* Once the threshold is reached, the neuron generates an action potential, a rapid, self-propagating change in membrane potential.
* The opening of voltage-gated sodium channels leads to a rapid influx of sodium ions, making the inside of the cell positively charged.
* This positive charge travels down the axon, the neuron's long, slender projection, like a wave.

**5. Repolarization:**
* As the action potential travels, sodium channels close, and potassium channels open.
* Potassium ions flow out of the cell, making the inside of the cell more negative again, returning it towards its resting potential.

**6. Hyperpolarization:**
* In some cases, the potassium channels stay open longer than necessary, causing the membrane potential to become even more negative than the resting potential, a state called hyperpolarization.
* This brief period of hyperpolarization ensures that the neuron does not fire another action potential too soon, preventing the signal from being scrambled.

**7. Refractory Period:**
* After the action potential, the neuron enters a refractory period during which it is less likely to fire another action potential. This ensures the signal travels in one direction.

**8. Synaptic Transmission:**
* When the action potential reaches the end of the axon, it triggers the release of neurotransmitters from synaptic vesicles into the synapse, the gap between neurons.
* These neurotransmitters bind to receptors on the postsynaptic neuron, initiating a new signal in the next neuron.

**9. Integration:**
* The postsynaptic neuron receives signals from multiple presynaptic neurons, some excitatory (promoting the firing of an action potential) and some inhibitory (suppressing the firing of an action potential).
* The postsynaptic neuron integrates these signals, determining whether or not to fire an action potential based on the balance of excitatory and inhibitory inputs.

**Key Factors Influencing Nerve Impulse Transmission:**
* **Myelination:** The presence of myelin, a fatty sheath surrounding the axon, speeds up conduction of the action potential.
* **Diameter of the axon:** Larger axons transmit signals faster than smaller axons.
* **Temperature:** Higher temperatures increase the speed of nerve impulse transmission.
* **Presence of drugs or toxins:** Some drugs or toxins can interfere with the normal function of neurons, affecting nerve impulse transmission.

This process of nerve impulse transmission is essential for all aspects of our nervous system, allowing us to sense the world around us, think, move, and perform countless other actions.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Growth hormone secretagogue receptor type 1A growth hormone secretagogue receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q92847]Homo sapiens (human)
Thymidine phosphorylaseA thymidine phosphorylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P19971]Homo sapiens (human)

Compounds (38)

CompoundDefinitionClassesRoles
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
floxuridinefloxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
idoxuridineorganoiodine compound;
pyrimidine 2'-deoxyribonucleoside
antiviral drug;
DNA synthesis inhibitor
bromodeoxyuridineBromodeoxyuridine: A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
trifluridinetrifluridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-trifluoromethyluracil as the nucleobase. An antiviral drug used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis.

Trifluridine: An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p557)
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
deoxyuridinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
substance ppeptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
captoprilcaptopril : A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.

Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
6-aminothymine6-aminothymine: inhibits degradation of nucleosides (idoxuridine, thymidine) & pyrimidine bases
5-chloro-2'-deoxyuridine
5-(2-propenyl)-2'-deoxyuridine
edoxudinpyrimidine 2'-deoxyribonucleoside
3-cyano-6-hydroxy-4-methyl-2-pyridone3-cyano-6-hydroxy-4-methyl-2-pyridone: structure in first source
6-amino-5-bromouracil
5-hydroxymethyl-2'-deoxyuridinepyrimidine 2'-deoxyribonucleoside
5-formyl-2'-deoxyuridine5-formyl-2'-deoxyuridine: structure given in first source
2,6-dihydroxy-3-cyanopyridine2,6-dihydroxy-3-cyanopyridine: inhibitor of 5-fluorouracil degradation
l 692429L 692429: stimulates release of growth hormone; RN refers to (R)-isomer; structure given in first source
5-nitro-2'-deoxyuridine
l 163191
cp 424391CP 424391: a growth hormone secretagogue; structure in first source
5-cyano-2'-deoxyuridine5-cyano-2'-deoxyuridine: structure in first source
ma-1tipiracil : A member of the class of pyrimidones that is uracil substituted by chloro and (2-iminopyrrolidin-1-yl)methyl groups at positions 5 and 6 respectively. Used (as the hydrochloride salt) in combination with trifluridine, a nucleoside metabolic inhibitor, for treatment of advanced/relapsed unresectable colorectal cancer.

tipiracil: inhibits thymidine phosphorylase
carboxamidine;
organochlorine compound;
pyrimidone;
pyrrolidines
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
5-(1-propenyl)-2'-deoxyuridine5-(1-propenyl)-2'-deoxyuridine: has anti-herpes activity; structure in first source
hexarelinhexarelin: a synthetic growth hormone releasing peptide; structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more potent & stable and less toxic than GHRP-6
sm 130686SM 130686: a growth hormone secretagogue; structure in first source
macimorelin
tabimorelintabimorelin: a growth hormone secretagogue; structure in first source
l 162752
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloridetipiracil hydrochloride : A hydrochloride obtained by combining tipiracil with one equivalent of hydrochloric acid. Used in combination with trifluridine, a nucleoside metabolic inhibitor, for treatment of advanced/relapsed unresectable colorectal cancer.hydrochloride;
iminium salt
antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
sk&f 110679
ulimorelinulimorelin: ghrelin agonist; an 18-membered macrocycle containing 3 amide bonds and a secondary amine as well as 4 stereogenic centers; belongs to macrocyclic peptidomimeticsoligopeptide
sesone7-deazaxanthine: structure in first source
n-(3-fluorophenyl)-1-((4-(((3s)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamineN-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine: a small molecule motilin receptor agonist; structure in first sourceacetamides
yil 781YIL 781: an appetite suppressant and weight loss promoter; structure in first source
nitd 609NITD 609: an antimalarial and coccidiostat; structure in first source
gsk 2334470GSK 2334470: a PDK1 inhibitor; structure in first sourceindazoles
5'-o-tritylinosine5'-O-tritylinosine: structure in first source